Mohali, India: A simple dispute over the placement of a vegetable cart escalated into a vicious attack on two brothers in Kumbran village, Sector-68. The incident led to the registration of a case of attempted murder against five suspects by the local police. The FIR was filed at Phase-8 police station based on the statement … Read more
New York, NY – A recent study delving into the causes of death among cancer patients undergoing CAR-T therapies has revealed concerning findings regarding nonrelapse causes of mortality. The study, conducted by researchers in New York, focused on understanding why some patients on CAR-T therapies are succumbing to causes other than cancer. The study emphasized … Read more
Orlando, Florida – A recent study on cancer patients receiving CAR-T therapies has shed light on the causes of death beyond disease relapse. The research delves into the various factors contributing to mortality among individuals undergoing this innovative treatment approach. The findings of the study reveal that a significant number of deaths among cancer patients … Read more
Silver Spring, Maryland – The FDA’s Oncologic Drugs Advisory Committee voted in favor of supporting the approvals of CAR-T therapies as earlier lines of treatment for multiple myeloma. Johnson & Johnson, Legend Biotech, Bristol Myers Squibb, and 2seventyBio’s therapies were discussed during the meeting, with a focus on the risks associated with early deaths in … Read more
Washington, D.C. – The FDA has raised concerns over early deaths in clinical trials for CAR-T therapies used to treat myeloma, a type of blood cancer. The trials involved Johnson & Johnson and Legend’s Carvykti, as well as Bristol Myers’ Abecma. The FDA is closely monitoring these trials to ensure patient safety and efficacy of … Read more
After multiple myeloma was diagnosed in Judith Harding in 2009, she made drastic life changes, expecting the worst. Meanwhile, Bill McHugh underwent a stem cell transplant for the same type of blood cancer in 2013. Their survival was once considered exceptional, but thanks to recent advancements in treatment, they are now considered typical multiple myeloma … Read more